Clinical trial
Analysis of Ergogenic Potential and Risks Associated With Acute and Chronic Use of Sulphonylureas on Physical Exercise
NCT04443777 is registered in ClinicalTrials.gov with Instituto de Cardiologia do Rio Grande do Sul as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Ergogenic Potential and Risks Associated With Acute and Chronic Use of Sulphonylureas on Physical Exercise
- Lead sponsor
- Instituto de Cardiologia do Rio Grande do Sul
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 1, 2020
- Completion date
- September 1, 2020
- Enrollment
- 44 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypoglycemic agents, muscle recovery, randomized controlled trial, resistance training, sport performance